Company Filing History:
Years Active: 2016
Title: Nadja Baenziger: Innovator in IL-17 Binding Compounds
Introduction
Nadja Baenziger is a prominent inventor based in Schlieren, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the development of IL-17 binding compounds. Her work focuses on innovative solutions for medical applications, showcasing her expertise and dedication to advancing healthcare.
Latest Patents
Nadja Baenziger holds 1 patent for her invention titled "IL-17 binding compounds and medical uses thereof." This patent relates to new IL-17 inhibiting polypeptides, corresponding fusion proteins, compositions, and their medical uses. Her invention aims to provide new therapeutic options for conditions associated with IL-17.
Career Highlights
Nadja is currently employed at Covagen AG, a company known for its cutting-edge research in biopharmaceuticals. Her role involves extensive research and development, contributing to the company's mission of creating innovative therapies. Her work has positioned her as a key figure in the biotechnology sector.
Collaborations
Nadja collaborates with talented professionals, including Dragan Grabulovski and Michela Silacci Melkko. These collaborations enhance her research efforts and contribute to the success of her projects.
Conclusion
Nadja Baenziger is a remarkable inventor whose work in IL-17 binding compounds is paving the way for new medical treatments. Her contributions to biotechnology reflect her commitment to innovation and improving patient outcomes.